Genpact Limited Stock Performance
G Stock | USD 30.56 0.07 0.23% |
The company retains a Market Volatility (i.e., Beta) of 1.05, which attests to a somewhat significant risk relative to the market. Genpact returns are very sensitive to returns on the market. As the market goes up or down, Genpact is expected to follow. Genpact Limited has an expected return of -0.21%. Please make sure to check out Genpact skewness, and the relationship between the total risk alpha and rate of daily change , to decide if Genpact Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Genpact Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Actual Historical Performance (%)
One Day Return (0.23) | Five Day Return (3.35) | Year To Date Return (12.13) | Ten Year Return 78.4 | All Time Return 82.45 |
Forward Dividend Yield 0.0199 | Payout Ratio 0.1896 | Forward Dividend Rate 0.61 | Dividend Date 2024-03-26 | Ex Dividend Date 2024-03-08 |
1 | Sale by Heather White of 11450 shares of Genpact | 01/24/2024 |
2 | Earnings call Genpact reports growth and new CEO transition | 02/09/2024 |
3 | Disposition of 1845 shares by Donald Klunk of Genpact at 36.2656 subject to Rule 16b-3 | 02/15/2024 |
4 | Westpac cuts 132 jobs across divisions, says trade union | 02/28/2024 |
Genpact dividend paid on 11th of March 2024 | 03/11/2024 |
5 | Wall Street Journal Ranks Genpact 2 in Customer Satisfaction on Management Top 250 List | 03/14/2024 |
6 | Acquisition by Donald Klunk of 3699 shares of Genpact subject to Rule 16b-3 | 03/15/2024 |
7 | Teachers Retirement System of The State of Kentucky Has 2.10 Million Stock Holdings in Genpact Limited - MarketBeat | 03/18/2024 |
8 | Acquisition by N Tyagarajan of 50000 shares of Genpact at 19.35 subject to Rule 16b-3 | 03/20/2024 |
9 | Genpact Recognized by Forbes as One of the Worlds Best Employers for Third Consecutive Year | 03/21/2024 |
Genpact dividend paid on 26th of March 2024 | 03/26/2024 |
10 | Global Insurance Business Process Outsourcing Report 2024 Market to Grow by 1.78 Billion During 2023-2028, Driven by AI, IoT, and Cloud-based Services | 04/03/2024 |
11 | Business Process Management Market To Reach USD 83.2 Billion By 2032 DataHorizzon Research | 04/05/2024 |
12 | Genpact to Announce First Quarter 2024 Results | 04/10/2024 |
13 | Genpacts CEO BK Kalra Joins Catalyst CEO Champions For Change | 04/12/2024 |
14 | Regulatory Affairs Outsourcing Market To Reach USD 13.1 Billion By 2032 DataHorizzon Research | 04/17/2024 |
Begin Period Cash Flow | 646.8 M |
Genpact |
Genpact Relative Risk vs. Return Landscape
If you would invest 3,520 in Genpact Limited on January 19, 2024 and sell it today you would lose (464.00) from holding Genpact Limited or give up 13.18% of portfolio value over 90 days. Genpact Limited is generating negative expected returns and assumes 1.427% volatility on return distribution over the 90 days horizon. Put is differently, 12% of stocks are less volatile than Genpact, and over 99% of all traded equities are expected to make higher returns on investment over the next 90 days. Expected Return |
Risk |
Genpact Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genpact's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Genpact Limited, and traders can use it to determine the average amount a Genpact's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.15
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | G |
Estimated Market Risk
1.43 actual daily | 12 88% of assets are more volatile |
Expected Return
-0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genpact is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genpact by adding Genpact to a well-diversified portfolio.
Genpact Fundamentals Growth
Genpact Stock prices reflect investors' perceptions of the future prospects and financial health of Genpact, and Genpact fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genpact Stock performance.
Return On Equity | 0.31 | |||
Return On Asset | 0.083 | |||
Profit Margin | 0.14 % | |||
Operating Margin | 0.14 % | |||
Current Valuation | 6.45 B | |||
Shares Outstanding | 180.33 M | |||
Price To Earning | 28.59 X | |||
Price To Book | 2.50 X | |||
Price To Sales | 1.26 X | |||
Revenue | 4.48 B | |||
Gross Profit | 1.54 B | |||
EBITDA | 630.86 M | |||
Net Income | 631.25 M | |||
Cash And Equivalents | 646.76 M | |||
Cash Per Share | 2.53 X | |||
Total Debt | 1.5 B | |||
Debt To Equity | 1.04 % | |||
Current Ratio | 1.58 X | |||
Book Value Per Share | 12.53 X | |||
Cash Flow From Operations | 490.81 M | |||
Earnings Per Share | 3.41 X | |||
Market Capitalization | 5.52 B | |||
Total Asset | 4.81 B | |||
Retained Earnings | 1.09 B | |||
Working Capital | 573.58 M | |||
Current Asset | 1.2 B | |||
Current Liabilities | 594.48 M | |||
About Genpact Performance
To evaluate Genpact Limited Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Genpact generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Genpact Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Genpact Limited market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Genpact's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 0.00000013 | 0.00 | |
Return On Tangible Assets | 0.21 | 0.22 | |
Return On Capital Employed | 0.18 | 0.1 | |
Return On Assets | 0.13 | 0.14 | |
Return On Equity | 0.28 | 0.29 |
Things to note about Genpact Limited performance evaluation
Checking the ongoing alerts about Genpact for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Genpact Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Genpact Limited generated a negative expected return over the last 90 days | |
Genpact Limited is unlikely to experience financial distress in the next 2 years | |
Over 99.0% of the company shares are owned by institutional investors | |
On 26th of March 2024 Genpact paid $ 0.1525 per share dividend to its current shareholders | |
Latest headline from finance.yahoo.com: Regulatory Affairs Outsourcing Market To Reach USD 13.1 Billion By 2032 DataHorizzon Research |
- Analyzing Genpact's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genpact's stock is overvalued or undervalued compared to its peers.
- Examining Genpact's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genpact's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genpact's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genpact's stock. These opinions can provide insight into Genpact's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Genpact Limited information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Genpact Stock analysis
When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.311 | Dividend Share 0.55 | Earnings Share 3.41 | Revenue Per Share 24.552 | Quarterly Revenue Growth 0.04 |
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.